Not Available
You May Also Like
The Square, a new film by Jehane Noujaim (Control Room; Rafea: Solar Mama), looks at the hard realities faced day-to-day by people working to build Egypt’s new democracy. Catapulting us into the action spread across 2011 and 2012, the film provides a kaleidoscopic, visceral experience of the struggle. Cairo’s Tahrir Square is the heart and soul of the film, which follows several young activists. Armed with values, determination, music, humor, an abundance of social media, and sheer obstinacy, they know that the thorny path to democracy only began with Hosni Mubarek’s fall. The life-and-death struggle between the people and the power of the state is still playing out.
With the rapid emergence of digital devices, an unstoppable, invisible force is changing human lives in ways from the microscopic to the gargantuan: Big Data, a word that was barely used a few years ago but now governs the day for many of us from the moment we awaken to the extinguishing of the final late-evening light bulb. This massive gathering and analyzing of data in real time is allowing us to not only address some of humanity biggest challenges but is also helping create a new kind of planetary nervous system. Yet as Edward Snowden and the release of the Prism documents have shown, the accessibility of all these data comes at a steep price. The Human Face of Big Data captures the promise and peril of this extraordinary knowledge revolution.
As most of the world moves forward toward gay equality, Russia is seemingly heading backward. Antigay sentiment and legislation are spreading rapidly throughout the country. In 2013, the Russian parliament passed a ban on so-called ‘gay propaganda’ that effectively makes nearly any public discussion of gay equality a crime. It is my hope that this documentary will educate viewers to their reality.
This documentary film includes never-before-seen footage and exclusive interviews to tell the story of Charity Hospital, from its roots to its controversial closing in the wake of Hurricane Katrina. From the firsthand accounts of healthcare providers and hospital employees who withstood the storm inside the hospital, to interviews with key players involved in the closing of Charity and the opening of New Orleans’ newest hospital, “Big Charity” shares the untold, true story around its closure and sheds new light on the sacrifices made for the sake of progress.
Two high school suicide clusters in six years rocks the affluent town of Palo Alto, California. Emotions run high and while no one has a silver bullet solution to this crisis, students rise up to make sure their voices are heard.
Honing his craft as an indie filmmaker in Germany in the early 90s, Uwe Boll never could have imagined the life that lay before him. From working with Oscar-winning actors and making films with US$60million budgets to having actors publicly disparage him and online petitions demanding he stop making films, Boll continued to work; he has a filmography of 32 features, a career that has led to his new life as a successful high-end restauranteur. Already a cult legend, he will be remembered forever in the film world; for some, as a modern-day Ed Wood, who made films so bad, they’re good, while for others, a prolific filmmaker who came from a small town in Germany and never compromised his integrity while forging his own unique Hollywood trajectory.
What would it be like if your last name was Hitler? Director Matt Ogens seeks that answer by intimately portraying a diverse group of individuals with that same unfortunate name.
This is the story of a man’s bravery to cover the world at war, and what it takes to get images published for the world to see. This is Jason P. Howe’s story of survival and change.
A story of two coalitions – ACT UP and TAG (Treatment Action Group) – whose activism and innovation turned AIDS from a death sentence into a manageable condition. Despite having no scientific training, these self-made activists infiltrated the pharmaceutical industry and helped identify promising new drugs, moving them from experimental trials to patients in record time.
